These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3021651)
81. Antiasthmatic activity of a novel thromboxane A2 antagonist, S-1452, in guinea pigs. Arimura A; Asanuma F; Kurosawa A; Harada M Int Arch Allergy Immunol; 1992; 98(3):239-46. PubMed ID: 1392626 [TBL] [Abstract][Full Text] [Related]
82. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845 [No Abstract] [Full Text] [Related]
83. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart. Hu W; Kinnaird AA; Man RY Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337 [TBL] [Abstract][Full Text] [Related]
85. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. Bourgain RH; Andries R; Braquet P Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():815-7. PubMed ID: 2960196 [TBL] [Abstract][Full Text] [Related]
86. Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs. Sakurai T; Yamaguchi S; Iwama T; Nagai H Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):95-9. PubMed ID: 7972272 [TBL] [Abstract][Full Text] [Related]
87. Failure of a combined anti-histamine and anti-leukotriene treatment to suppress passive anaphylaxis in the guinea-pig. Garcez Do Carmo L; Cordeiro R; Lagente V; Lefort J; Randon J; Vargaftig BB Int J Immunopharmacol; 1986; 8(8):985-95. PubMed ID: 2879805 [TBL] [Abstract][Full Text] [Related]
88. Effects of PAF on excitatory neuro-effector transmission in dog airways. Tashiro K; Xie Z; Ito Y Br J Pharmacol; 1992 Dec; 107(4):956-63. PubMed ID: 1334755 [TBL] [Abstract][Full Text] [Related]
89. Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung. Sirois P; Roy S; Borgeat P; Picard S; Vallerand P Prostaglandins Leukot Med; 1982 Feb; 8(2):157-70. PubMed ID: 6281811 [TBL] [Abstract][Full Text] [Related]
90. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407 [TBL] [Abstract][Full Text] [Related]
91. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855 [TBL] [Abstract][Full Text] [Related]
92. Biologic properties of LTB4 and paf-acether in vivo in human skin. Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030 [TBL] [Abstract][Full Text] [Related]
93. Neutrophil aggregating properties of PAF-acether and leukotriene B4. Ford-Hutchinson AW Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012 [TBL] [Abstract][Full Text] [Related]
94. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954 [TBL] [Abstract][Full Text] [Related]
95. Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. Dupont L; Germain G; Dideberg O Pharmacol Res Commun; 1986 Aug; 18 Suppl():25-32. PubMed ID: 3774849 [TBL] [Abstract][Full Text] [Related]
96. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397 [TBL] [Abstract][Full Text] [Related]
97. Platelet-activating factor-induced calcium mobilization in human platelets and neutrophils: effects of PAF-acether antagonists. Selak MA; Smith JB J Lipid Mediat; 1989; 1(2):125-37. PubMed ID: 2519888 [TBL] [Abstract][Full Text] [Related]
98. Some effects of leukotriene D4 on the mechanical properties of the guinea-pig basilar artery. Nishiye E; Itoh T; Kuriyama H Br J Pharmacol; 1988 Mar; 93(3):591-600. PubMed ID: 3259445 [TBL] [Abstract][Full Text] [Related]
99. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021. Jancar S; Braquet P; Sirois P Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218 [TBL] [Abstract][Full Text] [Related]
100. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021. Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]